Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Net Margin (2019 - 2023)

Historic Net Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 65114.29%.

  • Benitec Biopharma's Net Margin changed N/A to 65114.29% in Q2 2023 from the same period last year, while for Mar 2024 it was 317257.14%, marking a year-over-year decrease of 2888689100.0%. This contributed to the annual value of 26082.67% for FY2023, which is 15813000.0% down from last year.
  • Benitec Biopharma's Net Margin amounted to 65114.29% in Q2 2023.
  • Benitec Biopharma's Net Margin's 5-year high stood at 8220.0% during Q2 2020, with a 5-year trough of 379500.0% in Q1 2021.
  • Moreover, its 5-year median value for Net Margin was 8051.85% (2023), whereas its average is 80666.78%.
  • Its Net Margin has fluctuated over the past 5 years, first tumbled by 2000000000bps in 2021, then soared by 2000000000bps in 2022.
  • Quarter analysis of 5 years shows Benitec Biopharma's Net Margin stood at 2719.48% in 2019, then crashed by -11891bps to 326100.0% in 2020, then surged by 94bps to 19384.0% in 2021, then crashed by -107bps to 40135.71% in 2022, then plummeted by -62bps to 65114.29% in 2023.
  • Its Net Margin stands at 65114.29% for Q2 2023, versus 8051.85% for Q1 2023 and 40135.71% for Q4 2022.